mitoxantrone has been researched along with Shock, Cardiogenic in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casarotto, D | 1 |
| Bottio, T | 1 |
| Gambino, A | 1 |
| Testolin, L | 1 |
| Gerosa, G | 1 |
1 other study available for mitoxantrone and Shock, Cardiogenic
| Article | Year |
|---|---|
The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiomyopathy, Dilated; Castleman Di | 2003 |